ACADIA Pharmaceuticals Inc. Common Stock Earnings Dividend

ACADIA Pharmaceuticals Inc. Common Stock’s revenue jumped 16.4% since last year same period to $307.96Mn in the Q2 2026. On a quarterly growth basis, ACADIA Pharmaceuticals Inc. Common Stock has generated 14.88% jump in its revenue since last 3-months.

ACADIA Pharmaceuticals Inc. Common Stock’s net profit jumped 18.13% since last year same period to $31.5Mn in the Q2 2026. On a quarterly growth basis, ACADIA Pharmaceuticals Inc. Common Stock has generated 766.1% jump in its net profits since last 3-months.

ACADIA Pharmaceuticals Inc. Common Stock’s net profit margin jumped 1.48% since last year same period to 10.23% in the Q2 2026. On a quarterly growth basis, ACADIA Pharmaceuticals Inc. Common Stock has generated 653.89% jump in its net profit margins since last 3-months.

ACADIA Pharmaceuticals Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at 0.21 - a 250% jump from last quarter’s estimates.

ACADIA Pharmaceuticals Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at 0.21.

ACADIA Pharmaceuticals Inc. Common Stock’s earning per share (EPS) jumped 12.5% since last year same period to 0.18 in the Q2 2026. This indicates that the ACADIA Pharmaceuticals Inc. Common Stock has generated 12.5% annual rate of jump in its earning per share (EPS) in the last 4 quarters.